Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04827576
Title Study of Magrolimab in Patients With Solid Tumors (ELEVATELung&UC)
Acronym ELEVATELung&UC
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Gilead Sciences
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | GBR | FRA | ESP

Additional content available in CKB BOOST